1. Home
  2. CTY vs RDVT Comparison

CTY vs RDVT Comparison

Compare CTY & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTY

City Therapeutics Inc. Common Stock

N/A

Current Price

$17.55

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Red Violet Inc.

RDVT

Red Violet Inc.

N/A

Current Price

$69.52

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CTY
RDVT
Founded
2023
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2026
2017

Fundamental Metrics

Financial Performance
Metric
CTY
RDVT
Price
$17.55
$69.52
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$37.33
★ $97.00
AVG Volume (30 Days)
★ 250.4K
136.9K
Earning Date
12-01-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 82.00
EPS
N/A
★ 0.99
Revenue
N/A
★ $90,252,000.00
Revenue This Year
$62.96
$19.00
Revenue Next Year
$7.47
$14.07
P/E Ratio
★ N/A
$70.17
Revenue Growth
N/A
★ 20.03
52 Week Low
$15.81
$33.40
52 Week High
$22.65
$83.15

Technical Indicators

Market Signals
Indicator
CTY
RDVT
Relative Strength Index (RSI) 41.04 36.83
Support Level $16.12 $64.15
Resistance Level $21.98 $71.68
Average True Range (ATR) 2.35 3.62
MACD -0.15 -0.81
Stochastic Oscillator 25.44 34.31

Price Performance

Historical Comparison
CTY
RDVT

About CTY City Therapeutics Inc. Common Stock

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

About RDVT Red Violet Inc.

Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.

Share on Social Networks: